2020 Targeting ALK - From Discovery to Frontline Treatment
6 Pogledi
• 07/30/23
0
0
Ugraditi
administrator
Pretplatnici
In this 'keynote', Dr. Yael Mosse presents on the discovery of ALK aberrations in neuroblastoma, their significance at diagnosis and at relapse, drug development strategies and plans to incorporate ALK inhibitors into frontline therapy with potential joint COG and SIOPEN studies, and germline ALK mutation.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari